Jan 10, 2022 / 06:15PM GMT
David Joshua Saxon - Needham & Company, LLC, Research Division - Analyst
Good afternoon. I'm David Saxon. I'm with the medtech research team here at Needham. Thanks for everyone joining us at the 24th Annual Needham Growth Conference. With me today is Azenta's CEO, Steve Schwartz; CFO, Lindon Robertson; and Director of Investor Relations, Sara Silverman.
Regarding the format of this afternoon session, the Azenta team will go through a presentation, and then we'll finish up with some Q&A. So if anyone in the audience has any questions, you can submit it in the box on your screen if you're logged into the Needham Conference portal. Or you can e-mail me directly at [email protected], and I'll do my best to work them in.
So with that, I'll turn it over to Steve.
Stephen S. Schwartz - Azenta, Inc. - CEO, President & Director
David, thank you, and thanks, everyone, for joining today. We're really delighted to have a chance to be here at the Needham Growth Conference. For Lindon and I, it's always the best way to start the year,
Azenta Inc at Needham Growth Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
